Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

538
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

689
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
689
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

1.1K
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

1.2K
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Giant Right Atrial Aneurysm: Observation Versus Intervention.

JACC. Case reports·2026
Same author

Primary surgical closure of complete sternal cleft in a neonate.

JTCVS techniques·2026
Same author

Mini-thoracotomy Access for Endovascular Aortic Stenting in Pediatric Patients.

Pediatric cardiology·2026
Same author

Double-Orifice Left Atrioventricular Valve in Atrioventricular Septal Defects.

The Annals of thoracic surgery·2026
Same author

ValveFit: An analysis-suitable B-spline-based surface fitting framework for patient-specific modeling of tricuspid valves.

Computer methods in applied mechanics and engineering·2025
Same author

Surgical management of a newborn with interrupted aortic arch and subaortic obstruction.

The Journal of thoracic and cardiovascular surgery·2025

Related Experiment Video

Updated: May 6, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

2.7K

When should a mechanical tricuspid valve replacement be considered?

Sameh M Said1, Harold M Burkhart1, Hartzell V Schaff1

  • 1Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

The Journal of Thoracic and Cardiovascular Surgery
|November 9, 2013
PubMed
Summary

Isolated mechanical tricuspid valve replacement (mTVR) has high early mortality but offers long-term survival. Mechanical valves may be suitable for select patients requiring anticoagulation and with good right ventricular function.

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.8K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

13.3K

Related Experiment Videos

Last Updated: May 6, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

2.7K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.8K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

13.3K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biomaterials Science

Background:

  • Isolated mechanical tricuspid valve replacement (mTVR) is an uncommon procedure with high reported early mortality.
  • Long-term outcomes of mTVR remain poorly understood, necessitating further investigation.

Purpose of the Study:

  • To evaluate the long-term outcomes of isolated mechanical tricuspid valve replacement (mTVR).

Main Methods:

  • A retrospective analysis of 64 patients who underwent isolated mTVR between 1980 and 2007.
  • Patient data included demographics, etiology of valve dysfunction, prior cardiac procedures, prosthesis type, and concomitant surgeries.
  • Follow-up data on survival, morbidity, and valve-related complications were collected.

Main Results:

  • The primary causes for mTVR were congenital abnormalities (70%) and carcinoid heart disease (20%).
  • Early mortality was 7.8%, with major morbidities including pacemaker implantation (14%) and reexploration for bleeding (3%).
  • Five- and 10-year survival rates were 65% and 58%, respectively, with no valve-related mortality, though valve thrombosis occurred in 8% of patients.

Conclusions:

  • Isolated mTVR is associated with increased early mortality.
  • Mechanical valves can be considered in specific cases, particularly when anticoagulation is required and right ventricular function is preserved.